SLCO1B1*13 is assigned uncertain function based on limited in vitro evidence and no clinical data. In in vitro studies, SLCO1B1*13 demonstrated reduced uptake of estrone sulfate and estradiol 17beta-glucuronide (11477075), as well as rifampin (12490595) compared to wildtype. Therefore, consensus among experts was uncertain function due to inadequate evidence.